EMIL D KAKKIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EMIL D KAKKIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EMIL D KAKKIS. EMIL D KAKKIS is a SVP, Business Operations in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a President & CEO in Ultragenyx Pharmaceutical Inc. ($RARE).
Address: C/O BIOMARIN PHARMACEUTICAL INC. 371 BEL MARIN KEYS BLVD., SUITE 210 NOVATO 94949 CA
Companies in which EMIL D KAKKIS is an Insider
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EMIL D KAKKIS: SVP, Business Operations
Holdings: 26,110 shares
Current Value: $2,321,440
Latest Transaction: May 07 2004
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EMIL D KAKKIS: President & CEO
Holdings: 595,200 shares
Current Value: $43,396,032
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of EMIL D KAKKIS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 115.71 | 852 | 98,585 | 595,200 | 596.1 K to 595.2 K (-0.14 %) |
| May 05 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 107.80 | 30,000 | 3,234,000 | 2,259,741 | 2.3 M to 2.3 M (-1.31 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Option Exercise | A | 142.47 | 36,000 | 5,128,920 | 36,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 141.80 | 30,000 | 4,254,000 | 2,289,741 | 2.3 M to 2.3 M (-1.29 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 142.47 | 16,342 | 2,328,245 | 596,052 | 612.4 K to 596.1 K (-2.67 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 15,453 | 0 | 612,394 | 596.9 K to 612.4 K (+2.59 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 18,000 | 0 | 596,941 | 578.9 K to 596.9 K (+3.11 %) |